FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220820124> ?p ?o ?g. }

• W4220820124 endingPage "721" @default.
• W4220820124 startingPage "712" @default.
• W4220820124 abstract "Coagulation dysfunction and thromboembolism emerge as strong comorbidity factors in severe COVID-19. However, it is unclear when particularly platelet activation markers and coagulation factors dysregulated during the pathogenesis of COVID-19. Here, we sought to assess the levels of coagulation and platelet activation markers at moderate and severe stages of COVID-19 to understand the pathogenesis.To understand this, hospitalized COVID-19 patients with (severe cases that required intensive care) or without pneumonia (moderate cases) were recruited. Phenotypic and molecular characterizations were performed employing basic coagulation tests including prothrombin time (PT), activated partial thromboplastin time (APTT), D-Dimer, and tissue factor pathway inhibitor (TFPI). The flow cytometry-based multiplex assays were performed to assess FXI, anti-thrombin, prothrombin, fibrinogen, FXIII, P-selectin, sCD40L, plasminogen, tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and D-Dimer.The investigations revealed induction of plasma P-selectin and CD40 ligand (sCD40L) in moderate COVID-19 cases, which were significantly abolished with the progression of COVID-19 severity. Moreover, a profound reduction in plasma tissue factor pathway inhibitor (TFPI) and FXIII were identified particularly in the severe COVID-19. Further analysis revealed fibrinogen induction in both moderate and severe patients. Interestingly, an elevated PAI-1 more prominently in moderate, and tPA particularly in severe COVID-19 cases were observed. Particularly, the levels of fibrinogen and tPA directly correlated with the severity of the disease.In summary, induction of soluble P-selectin, sCD40L, fibrinogen, and PAI-1 suggests the activation of platelets and coagulation system at the moderate stage before COVID-19 patients require intensive care. These findings would help in designing better thromboprophylaxis to limit the COVID-19 severity." @default.
• W4220820124 created "2022-04-03" @default.
• W4220820124 creator A5001481428 @default.
• W4220820124 creator A5012858020 @default.
• W4220820124 creator A5024214986 @default.
• W4220820124 creator A5035909589 @default.
• W4220820124 creator A5038600313 @default.
• W4220820124 creator A5043109607 @default.
• W4220820124 creator A5048991804 @default.
• W4220820124 creator A5061105475 @default.
• W4220820124 creator A5088614548 @default.
• W4220820124 date "2022-03-09" @default.
• W4220820124 modified "2023-10-17" @default.
• W4220820124 title "SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐19" @default.
• W4220820124 cites W1546689286 @default.
• W4220820124 cites W1561516029 @default.
• W4220820124 cites W1855371734 @default.
• W4220820124 cites W1947193815 @default.
• W4220820124 cites W1971054351 @default.
• W4220820124 cites W1972950962 @default.
• W4220820124 cites W1974436153 @default.
• W4220820124 cites W1974514823 @default.
• W4220820124 cites W1983318857 @default.
• W4220820124 cites W1983927535 @default.
• W4220820124 cites W2021319806 @default.
• W4220820124 cites W2031636542 @default.
• W4220820124 cites W2037466316 @default.
• W4220820124 cites W2086267154 @default.
• W4220820124 cites W2095872378 @default.
• W4220820124 cites W2102415093 @default.
• W4220820124 cites W2106046020 @default.
• W4220820124 cites W2118902632 @default.
• W4220820124 cites W2127367952 @default.
• W4220820124 cites W2131228216 @default.
• W4220820124 cites W213274287 @default.
• W4220820124 cites W2152688263 @default.
• W4220820124 cites W2160613916 @default.
• W4220820124 cites W2160910731 @default.
• W4220820124 cites W2293439019 @default.
• W4220820124 cites W2335231905 @default.
• W4220820124 cites W2482048902 @default.
• W4220820124 cites W2801276228 @default.
• W4220820124 cites W2935704207 @default.
• W4220820124 cites W2946444763 @default.
• W4220820124 cites W2996192796 @default.
• W4220820124 cites W3008461878 @default.
• W4220820124 cites W3008827533 @default.
• W4220820124 cites W3012421327 @default.
• W4220820124 cites W3012422150 @default.
• W4220820124 cites W3013488343 @default.
• W4220820124 cites W3014099229 @default.
• W4220820124 cites W3015863623 @default.
• W4220820124 cites W3016965546 @default.
• W4220820124 cites W3019830619 @default.
• W4220820124 cites W3020168167 @default.
• W4220820124 cites W3023873927 @default.
• W4220820124 cites W3028989873 @default.
• W4220820124 cites W3029923949 @default.
• W4220820124 cites W3039456903 @default.
• W4220820124 cites W3040254875 @default.
• W4220820124 cites W3041582510 @default.
• W4220820124 cites W3044231876 @default.
• W4220820124 cites W3045020713 @default.
• W4220820124 cites W3081892816 @default.
• W4220820124 cites W3118978773 @default.
• W4220820124 cites W3125908954 @default.
• W4220820124 cites W3126648876 @default.
• W4220820124 cites W3128164510 @default.
• W4220820124 cites W3130264704 @default.
• W4220820124 cites W3138991590 @default.
• W4220820124 cites W3157304674 @default.
• W4220820124 cites W3165656738 @default.
• W4220820124 cites W3172155398 @default.
• W4220820124 cites W3209464601 @default.
• W4220820124 cites W4220820124 @default.
• W4220820124 doi "https://doi.org/10.1111/ijlh.13829" @default.
• W4220820124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35266284" @default.
• W4220820124 hasPublicationYear "2022" @default.
• W4220820124 type Work @default.
• W4220820124 citedByCount "21" @default.
• W4220820124 countsByYear W42208201242022 @default.
• W4220820124 countsByYear W42208201242023 @default.
• W4220820124 crossrefType "journal-article" @default.
• W4220820124 hasAuthorship W4220820124A5001481428 @default.
• W4220820124 hasAuthorship W4220820124A5012858020 @default.
• W4220820124 hasAuthorship W4220820124A5024214986 @default.
• W4220820124 hasAuthorship W4220820124A5035909589 @default.
• W4220820124 hasAuthorship W4220820124A5038600313 @default.
• W4220820124 hasAuthorship W4220820124A5043109607 @default.
• W4220820124 hasAuthorship W4220820124A5048991804 @default.
• W4220820124 hasAuthorship W4220820124A5061105475 @default.
• W4220820124 hasAuthorship W4220820124A5088614548 @default.
• W4220820124 hasBestOaLocation W42208201242 @default.
• W4220820124 hasConcept C126322002 @default.
• W4220820124 hasConcept C186738567 @default.
• W4220820124 hasConcept C203014093 @default.
• W4220820124 hasConcept C2777151630 @default.
• W4220820124 hasConcept C2778261982 @default.

• next